Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methylnaltrexone bromide (MOA-728) is one of the newer agents of peripherally-acting μ-opioid antagonists. Methylnaltrexone bromide acts to reverse some of the side effects of opioid drugs such as constipation without affecting analgesia or precipitating withdrawals.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 77.00 | |
10 mg | In stock | $ 118.00 | |
25 mg | In stock | $ 200.00 | |
50 mg | In stock | $ 286.00 | |
100 mg | In stock | $ 497.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 91.00 |
Description | Methylnaltrexone bromide (MOA-728) is one of the newer agents of peripherally-acting μ-opioid antagonists. Methylnaltrexone bromide acts to reverse some of the side effects of opioid drugs such as constipation without affecting analgesia or precipitating withdrawals. |
Synonyms | Relistor, MOA-728, MOA 728, Methylnaltrexone, MOA728 |
Molecular Weight | 436.35 |
Formula | C21H26BrNO4 |
CAS No. | 73232-52-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: 60 mg/ml (137.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methylnaltrexone bromide 73232-52-7 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor inhibit suppression gastrointestinal blood-brain tract Relistor peripheral Methylnaltrexone Bromide barrier MOA-728 analgesia MOA 728 Methylnaltrexone Inhibitor MOA728 inhibitor